Craft

GenMark Diagnostics

Revenue

$171.6 M

FY, 2020

GenMark Diagnostics Summary

Company Summary

Overview
GenMark Diagnostics is a provider of multiplex molecular diagnostic solutions. It develops the ePlex system, a solution that streamlines a diagnostic workflow from physician order entry to the release of the report, XT-8 system, a multiplex molecular testing, offering post-PCR detection for infectious disease, genetics, and pharmacogenetics targets, and other products.
Type
Subsidiary
Status
Active
Founded
2010
HQ
Carlsbad, CA, US | view all locations
Website
https://www.genmarkdx.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Tanya Monga

    Tanya Monga, Chief Executive Officer

  • Christine Shaw

    Christine Shaw, Vice President, Assay Development

  • Alan Maderazo

    Alan Maderazo, Vice President, Quality, Regulatory, & Clinical Affairs

  • Jeremy Kiger

    Jeremy Kiger, Head of Product Strategy & International Business

Operating MetricsView all

Global Customers

12K

FY, 2020

Trademarks

4

FY, 2020

Facility Space Leased, sq. ft.

160K
83.9%

FY, 2020

LocationsView all

2 locations detected

  • Carlsbad, CA HQ

    United States

    5964 La Place Ct

  • Carlsbad, CA

    United States

    2210 Faraday Ave

GenMark Diagnostics Financials

Summary Financials

Revenue (FY, 2020)
$171.6M
Gross profit (FY, 2020)
$67.9M
Net income (FY, 2020)
($18.6M)
Cash (FY, 2020)
$40.6M
EBIT (FY, 2020)
($11.1M)

Footer menu